| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $24,048,250 ) (Continued on the next page) |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 Danny Thomas Pl | Memphis | TN | 38105-3678 | SHELBY | USA | T2331578 | Children's Hospitals Graduate Medical Education Payment Program | 00 | 8 | HRSA | 12/9/2024 | $244,155 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA290805 | Targeting the chromatin binding domains of BPTF for neuroblastoma epigenetic therapy | 000 | 1 | NIH | 12/30/2024 | $738,024 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM157243 | Deciphering the genetic regulation of bacterial heterogeneity in response to antibiotic stress using single-cell transcriptomics | 000 | 1 | NIH | 12/24/2024 | $462,500 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS139519 | Polarity Signals Coordinate Neuronal Differentiation & Nuclear Organization | 000 | 1 | NIH | 11/22/2024 | $676,388 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA289881 | Targetable epigenetic modifiers that promote neuroblastoma malignancy and plasticity | 000 | 1 | NIH | 1/10/2025 | $718,113 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01MH136215 | Cooperative dysfunction of thalamocortical and cerebellar inputs to the auditory cortex in 22q11.2 deletion syndrome model of schizophrenia. | 001 | 1 | NIH | 11/29/2024 | $9,436 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01MH136215 | Cooperative dysfunction of thalamocortical and cerebellar inputs to the auditory cortex in 22q11.2 deletion syndrome model of schizophrenia. | 000 | 1 | NIH | 11/27/2024 | $721,599 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01EY037117 | The Role of Müller Glia in Acute and Chronic Response to Stress, Injury, and Disease in the Retina | 000 | 1 | NIH | 1/15/2025 | $606,034 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS100939 | Sonic Hedgehog Signaling in Neocortical Growth and Folding | 001 | 7 | NIH | 1/7/2025 | $513,534 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM122462 | Structure and functional mechanisms of molecular chaperones and protein kinases | 001 | 9 | NIH | 2/24/2025 | $687,854 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA259581 | Elucidating the Functional and Mechanistic Roles of LINE-1 Retrotransposons in Myeloid Leukemia | 001 | 5 | NIH | 11/22/2024 | $0 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA259581 | Elucidating the Functional and Mechanistic Roles of LINE-1 Retrotransposons in Myeloid Leukemia | 000 | 5 | NIH | 11/15/2024 | $433,868 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K08CA266935 | IMPROVING PROGNOSTIC COMMUNICATION IN PEDIATRIC CANCER | 000 | 3 | NIH | 11/12/2024 | $252,084 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI099394 | Mechanistic Studies Of The Staphylococcus aureus LukAB Cytotoxin | 001 | 11 | NIH | 11/14/2024 | $19,124 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI099394 | Mechanistic Studies Of The Staphylococcus aureus LukAB Cytotoxin | 000 | 11 | NIH | 11/6/2024 | $618,329 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA251436 | Mediators Of Arrested Differentiation In Pediatric Rhabdomyosarcoma | 000 | 5 | NIH | 1/13/2025 | $369,546 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS116361 | Deciphering the Role of Aberrant Endogenous Retroviral Expression in Onco-histone Driven Glioma | 000 | 4 | NIH | 12/3/2024 | $518,525 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01GM144566 | Structural Basis of Programmable DNA-Insertion via Cryo-EM Studies of CRISPR-Associated TnsC | 003 | 4 | NIH | 12/9/2024 | $343,981 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R21AI178085 | Trivalent Live Attenuated Vaccines for Bacterial Acute Otitis Media | 000 | 2 | NIH | 12/9/2024 | $220,675 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R21AI178084 | Characterization of TCS11 in Streptococcus pneumoniae | 000 | 2 | NIH | 12/9/2024 | $220,675 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AG075869 | REGULATION OF PROTEOSTASIS AND TAUOPATHY BY MALTOSE-INDUCED SIGNALING | 000 | 2 | NIH | 1/23/2025 | $416,250 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS133147 | Structural and functional investigations on synaptic vesicular transporters | 000 | 2 | NIH | 2/20/2025 | $471,050 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K08CA255569 | WT1 as an oncogene and therapeutic target in anaplastic Wilms tumor | 000 | 5 | NIH | 12/12/2024 | $194,741 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS121114 | Understanding the sequence and structural determinants of phase behavior of ALS-causing proteins | 000 | 5 | NIH | 2/20/2025 | $561,572 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R21CA280230 | Cardiopulmonary function and cerebral blood flow in Hodgkin Lymphoma survivors | 000 | 2 | NIH | 1/3/2025 | $191,442 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R37CA286444 | Dissecting high-risk cell states in neuroblastoma | 000 | 2 | NIH | 2/14/2025 | $533,298 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA270785 | Mapping the Cerebellar Origins of Medulloblastoma Subgroups | 000 | 3 | NIH | 12/31/2024 | $619,886 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K08CA279926 | Decoding the epigenetic landscape that delineates T cell homeostatic proliferation from uncontrolled growth” | 000 | 2 | NIH | 11/27/2024 | $263,778 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA260175 | XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION | 000 | 4 | NIH | 2/13/2025 | $374,693 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA262589 | Enhancing B7-H3-CAR T cell therapy for pediatric solid tumors | 000 | 4 | NIH | 2/18/2025 | $679,069 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI168214 | Consequences of Direct Viral-Bacterial Interactions | 000 | 4 | NIH | 12/9/2024 | $487,212 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA273455 | Cancer-based discovery of novel mechanisms of chromatin control | 000 | 3 | NIH | 3/6/2025 | $374,693 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA262790 | The Role of Immature Tumor Subpopulations In Pediatric Rhabdomyosarcoma | 000 | 4 | NIH | 2/13/2025 | $374,693 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI192221 | [18F]fluoromannitol: A novel imaging agent to delineate osteomyelitis in sickle cell disease | 000 | 1 | NIH | 2/26/2025 | $894,735 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | T32HL176447 | Basic and Translational Research Training in Pediatric Classical Hematology | 000 | 1 | NIH | 12/26/2024 | $252,285 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM141947 | Pharmacogenetics of Nucleobase and Nucleoside Analog Drugs | 001 | 5 | NIH | 2/19/2025 | $516,960 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01GM141357 | Molecular Mechanisms Underlying Mammalian NADPH Oxidase Activation and Regulation | 000 | 5 | NIH | 2/20/2025 | $323,100 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS121249 | Improving genetically engineered T cells for medulloblastomas | 000 | 5 | NIH | 3/11/2025 | $400,298 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI153138 | Robust immune tolerance conferred by Foxp3 transcriptional regulation | 000 | 5 | NIH | 12/18/2024 | $435,288 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA245301 | Regulation of collagen linearization during cancer progression and metastasis | 000 | 5 | NIH | 3/4/2025 | $369,546 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R37AI105887 | Metabolic checkpoint in dendritic cell subsets and adaptive immunity | 000 | 12 | NIH | 12/3/2024 | $455,000 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI131703 | Regulation of T cell memory in tissue immunity | 000 | 6 | NIH | 11/13/2024 | $538,352 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI128756 | Bioactivities of pneumococcal cell wall in neuropathogenesis | 000 | 9 | NIH | 1/21/2025 | $441,350 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA194057 | Transporters and Medulloblastoma | 000 | 10 | NIH | 3/14/2025 | $365,852 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U24CA055727 | Childhood Cancer Survivorship Study | 001 | 31 | NIH | 3/5/2025 | $3,024,600 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 Danny Thomas Pl | Memphis | TN | 38105-3678 | SHELBY | USA | T2331578 | Children's Hospitals Graduate Medical Education Payment Program | 00 | 8 | HRSA | 12/9/2024 | $52,683 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R21NS142525 | Investigating the role of RHOBTB2 in DEE to develop novel therapies | 000 | 1 | NIH | 2/28/2025 | $277,500 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA113794 | The function of Snf5 (SMARCB1), an epigenetic tumor suppressor | 000 | 21 | NIH | 11/21/2024 | $381,159 |
| | 2025 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01DK132902 | Mechanistic Basis of Calcium Sensing Receptor Signaling | 001 | 4 | NIH | 1/11/2025 | $317,220 |
|
